Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 2
1978 5
1979 2
1988 1
1989 1
1990 1
1991 1
1992 1
1993 1
1995 2
1996 3
1997 3
1998 1
1999 4
2000 4
2001 4
2002 3
2003 6
2004 5
2005 10
2006 5
2007 6
2008 9
2009 10
2010 10
2011 8
2012 10
2013 13
2014 4
2015 8
2016 9
2017 8
2018 12
2019 6
2020 11
2021 9
2022 11
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Results by year

Filters applied: . Clear all
Page 1
CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes.
Koyama-Nasu R, Kimura MY, Kiuchi M, Aoki A, Wang Y, Mita Y, Hasegawa I, Endo Y, Onodera A, Hirahara K, Motohashi S, Nakayama T. Koyama-Nasu R, et al. Among authors: motohashi s. Cancer Immunol Res. 2023 Aug 3;11(8):1085-1099. doi: 10.1158/2326-6066.CIR-22-0406. Cancer Immunol Res. 2023. PMID: 37216576
Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B+ vesicle pathway in liver cancer.
Yamada K, Motohashi S, Oikawa T, Tago N, Koizumi R, Ono M, Tachibana T, Yoshida A, Yoshida S, Shimoda M, Oka M, Yoneda Y, Yoshida K. Yamada K, et al. Among authors: motohashi s. Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2202730119. doi: 10.1073/pnas.2202730119. Epub 2022 Aug 31. Proc Natl Acad Sci U S A. 2022. PMID: 36044553 Free PMC article.
[Cancer Immunotherapy Using Allogeneic NKT Cells].
Aoki T, Motohashi S. Aoki T, et al. Among authors: motohashi s. Gan To Kagaku Ryoho. 2023 May;50(5):584-588. Gan To Kagaku Ryoho. 2023. PMID: 37218316 Clinical Trial. Japanese.
Adjuvant activity mediated by iNKT cells.
Fujii S, Motohashi S, Shimizu K, Nakayama T, Yoshiga Y, Taniguchi M. Fujii S, et al. Among authors: motohashi s. Semin Immunol. 2010 Apr;22(2):97-102. doi: 10.1016/j.smim.2009.10.002. Epub 2009 Nov 24. Semin Immunol. 2010. PMID: 19939703 Review.
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.
Ogawa K, Chiba T, Nakamura M, Arai J, Zhang J, Ma Y, Qiang NA, Ao J, Yumita S, Ishino T, Kan M, Iwanaga T, Nakagawa M, Fujiwara K, Sakuma T, Kanzaki H, Koroki K, Kusakabe Y, Kobayashi K, Kanogawa N, Kiyono S, Kondo T, Nakagawa R, Ogasawara S, Muroyama R, Nakamoto S, Kanda T, Maruyama H, Kato J, Matsumoto S, Arai T, Motohashi S, Kato N. Ogawa K, et al. Among authors: motohashi s. Anticancer Res. 2023 Mar;43(3):1043-1052. doi: 10.21873/anticanres.16249. Anticancer Res. 2023. PMID: 36854524
NKT cells as an ideal anti-tumor immunotherapeutic.
Fujii S, Shimizu K, Okamoto Y, Kunii N, Nakayama T, Motohashi S, Taniguchi M. Fujii S, et al. Among authors: motohashi s. Front Immunol. 2013 Dec 2;4:409. doi: 10.3389/fimmu.2013.00409. Front Immunol. 2013. PMID: 24348476 Free PMC article. Review.
198 results